Skip to content

Clinical trials

Observational Hemorrhage trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Observational Country / region: Netherlands Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20111
20121
20141
20182
20201
20211
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
AstraZeneca1
European Society of Anaesthesiology1
Fondazione Angelo Bianchi Bonomi1
Janssen-Cilag B.V.1
Karolinska Institutet1
Leiden University Medical Center1
R&D Cardiologie1
Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research1
St. Antonius Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage11
Thrombosis3
Cardiovascular Diseases2
Thrombocytopenia, Neonatal Alloimmune2
Acute Coronary Syndrome1
Acute Disease1
Acute Kidney Injury1
Anaphylaxis1
Anemia1
Atrial Fibrillation1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.